Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	actin filament binding	FLII MYH4 MYH6 MYH7 MYH8 SPTA1 NEB LCP1 ACTR3 SCIN FMNL1	5.61e-07	227	139	11	GO:0051015
GeneOntologyMolecularFunction	actin binding	FLII MYH4 MYH6 MYH7 MYH8 CALD1 SPTA1 NEB LCP1 ACTR3 ARC SCIN FMNL1	3.09e-05	479	139	13	GO:0003779
GeneOntologyMolecularFunction	cytoskeletal protein binding	FLII MAP9 MYH4 MYH6 MYH7 MYH8 SPAST CALD1 SPTA1 APC2 NEB LCP1 ACTR3 KIF20B KIFAP3 ARC SCIN CNGA3 FMNL1 FBXW11	7.52e-05	1099	139	20	GO:0008092
GeneOntologyMolecularFunction	ubiquitin-protein transferase regulator activity	GBP6 GLMN FBXO5 BTRC	9.96e-05	35	139	4	GO:0055106
GeneOntologyMolecularFunction	protein phosphatase binding	VIM HSP90B2P PECAM1 SMG5 GHR KIFAP3 TBK1 CDH2	1.14e-04	210	139	8	GO:0019903
GeneOntologyMolecularFunction	ubiquitin-protein transferase inhibitor activity	GBP6 GLMN FBXO5	1.14e-04	14	139	3	GO:0055105
GeneOntologyMolecularFunction	microfilament motor activity	MYH4 MYH6 MYH7 MYH8	1.38e-04	38	139	4	GO:0000146
GeneOntologyMolecularFunction	phosphatase binding	VIM HSP90B2P PECAM1 SMG5 GHR KIFAP3 TBK1 CDH2	5.32e-04	264	139	8	GO:0019902
GeneOntologyMolecularFunction	keratin filament binding	VIM KRT14	7.09e-04	6	139	2	GO:1990254
GeneOntologyMolecularFunction	ATP hydrolysis activity	MYH4 MYH7 MYH8 HSP90B2P SPAST DHX38 CHD7 KIF20B DDX60L YME1L1	1.06e-03	441	139	10	GO:0016887
GeneOntologyMolecularFunction	calmodulin binding	MYH4 MYH6 MYH7 MYH8 CALD1 RYR3 EEA1	1.16e-03	230	139	7	GO:0005516
GeneOntologyMolecularFunction	ATP-dependent activity	TTF2 MYH4 MYH6 MYH7 MYH8 HSP90B2P SPAST DHX38 CHD7 KIF20B DDX60L YME1L1	1.23e-03	614	139	12	GO:0140657
GeneOntologyBiologicalProcess	supramolecular fiber organization	VIM FLII MYH6 MYH7 KRT14 HSP90B2P SPAST KRT17 CALD1 PDGFRA SPTA1 PECAM1 APC2 ASAP3 CASP4 NEB LCP1 ACTR3 USP8 KRT24 FBXO5 ARHGAP25 ADPRHL1 SCIN	2.80e-08	957	140	24	GO:0097435
GeneOntologyBiologicalProcess	muscle filament sliding	MYH4 MYH6 MYH7 MYH8	2.62e-06	15	140	4	GO:0030049
GeneOntologyBiologicalProcess	actin-myosin filament sliding	MYH4 MYH6 MYH7 MYH8	5.78e-06	18	140	4	GO:0033275
GeneOntologyBiologicalProcess	actin filament-based process	FLII MYH4 MYH6 MYH7 MYH8 HSP90B2P CALD1 PDGFRA SPTA1 PECAM1 ASAP3 CASP4 NEB LCP1 ACTR3 ARHGAP25 ADPRHL1 SCIN FMNL1	1.33e-05	912	140	19	GO:0030029
GeneOntologyBiologicalProcess	myofibril assembly	FLII MYH6 MYH7 PDGFRA NEB ADPRHL1	2.64e-05	86	140	6	GO:0030239
GeneOntologyBiologicalProcess	striated muscle cell development	FLII MYH6 MYH7 PDGFRA NEB ADPRHL1	3.21e-05	89	140	6	GO:0055002
GeneOntologyBiologicalProcess	actin cytoskeleton organization	FLII MYH6 MYH7 HSP90B2P CALD1 PDGFRA SPTA1 PECAM1 ASAP3 CASP4 NEB LCP1 ACTR3 ARHGAP25 ADPRHL1 SCIN FMNL1	3.23e-05	803	140	17	GO:0030036
GeneOntologyBiologicalProcess	intermediate filament cytoskeleton organization	VIM KRT14 ARHGEF28 KRT17 KRT24 PRPH	5.86e-05	99	140	6	GO:0045104
GeneOntologyBiologicalProcess	intermediate filament-based process	VIM KRT14 ARHGEF28 KRT17 KRT24 PRPH	6.20e-05	100	140	6	GO:0045103
GeneOntologyBiologicalProcess	microtubule-based movement	SPAST ACTR3 KIF20B CFAP65 FSIP2 DNAAF5 KIFAP3 SLC9C1 TEKT2 INTS13 ARHGAP21 FBXW11	1.39e-04	493	140	12	GO:0007018
GeneOntologyBiologicalProcess	actin filament organization	FLII HSP90B2P CALD1 SPTA1 PECAM1 ASAP3 CASP4 NEB LCP1 ACTR3 ARHGAP25 SCIN	1.87e-04	509	140	12	GO:0007015
GeneOntologyBiologicalProcess	adult heart development	MYH6 MYH7 CHD7	2.32e-04	18	140	3	GO:0007512
GeneOntologyBiologicalProcess	actin filament severing	FLII SCIN FMNL1	2.32e-04	18	140	3	GO:0051014
GeneOntologyCellularComponent	supramolecular fiber	LDLRAP1 VIM MAP9 MYH4 MYH6 MYH7 MYH8 KRT14 SPAST KRT17 CALD1 PECAM1 APC2 NEB LCP1 ACTR3 KIF20B PGM1 RYR3 KIFAP3 TEKT2 KRT24 ADPRHL1 FBXW11 PRPH	2.34e-07	1179	139	25	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	LDLRAP1 VIM MAP9 MYH4 MYH6 MYH7 MYH8 KRT14 SPAST KRT17 CALD1 PECAM1 APC2 NEB LCP1 ACTR3 KIF20B PGM1 RYR3 KIFAP3 TEKT2 KRT24 ADPRHL1 FBXW11 PRPH	2.65e-07	1187	139	25	GO:0099081
GeneOntologyCellularComponent	muscle myosin complex	MYH4 MYH6 MYH7 MYH8	3.20e-06	16	139	4	GO:0005859
GeneOntologyCellularComponent	actin cytoskeleton	FLII MYH4 MYH6 MYH7 MYH8 CALD1 SPTA1 APC2 NEB LCP1 ACTR3 ARC SCIN CDH2 ARHGAP21	7.02e-06	576	139	15	GO:0015629
GeneOntologyCellularComponent	myosin filament	MYH4 MYH6 MYH7 MYH8	2.12e-05	25	139	4	GO:0032982
GeneOntologyCellularComponent	contractile muscle fiber	MYH4 MYH6 MYH7 MYH8 CALD1 PECAM1 NEB PGM1 RYR3 ADPRHL1	2.50e-05	290	139	10	GO:0043292
GeneOntologyCellularComponent	myosin II complex	MYH4 MYH6 MYH7 MYH8	3.39e-05	28	139	4	GO:0016460
GeneOntologyCellularComponent	myofibril	MYH4 MYH6 MYH7 MYH8 CALD1 NEB PGM1 RYR3 ADPRHL1	9.05e-05	273	139	9	GO:0030016
GeneOntologyCellularComponent	sarcomere	MYH4 MYH6 MYH7 MYH8 NEB PGM1 RYR3 ADPRHL1	2.67e-04	249	139	8	GO:0030017
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	LDLRAP1 VIM MAP9 KRT14 SPAST KRT17 CALD1 APC2 LCP1 ACTR3 KIF20B KIFAP3 TEKT2 KRT24 FBXW11 PRPH	3.22e-04	899	139	16	GO:0099513
GeneOntologyCellularComponent	dopaminergic synapse	CHRNA3 VPS35 NLGN2	4.04e-04	22	139	3	GO:0098691
GeneOntologyCellularComponent	myosin complex	MYH4 MYH6 MYH7 MYH8	6.42e-04	59	139	4	GO:0016459
GeneOntologyCellularComponent	type III intermediate filament	VIM PRPH	6.47e-04	6	139	2	GO:0045098
GeneOntologyCellularComponent	midbody	HSP90B2P SPAST APC2 KIF20B USP8 CCDC124 TACC1	7.23e-04	222	139	7	GO:0030496
GeneOntologyCellularComponent	axon	LDLRAP1 VIM MAP9 SPAST PDGFRA SPTA1 DSCAML1 KIF20B NLGN2 EEA1 CNGA3 FBXW11 GABRA2 LGI1 PRPH	8.80e-04	891	139	15	GO:0030424
Domain	Myosin_N	MYH4 MYH6 MYH7 MYH8	3.55e-06	15	137	4	PF02736
Domain	Myosin_N	MYH4 MYH6 MYH7 MYH8	3.55e-06	15	137	4	IPR004009
Domain	Myosin_tail_1	MYH4 MYH6 MYH7 MYH8	7.83e-06	18	137	4	PF01576
Domain	Myosin_tail	MYH4 MYH6 MYH7 MYH8	7.83e-06	18	137	4	IPR002928
Domain	Myosin-like_IQ_dom	MYH4 MYH6 MYH7 MYH8	9.86e-06	19	137	4	IPR027401
Domain	-	MYH4 MYH6 MYH7 MYH8	9.86e-06	19	137	4	4.10.270.10
Domain	Keratin_I	VIM KRT14 KRT17 KRT24 PRPH	1.70e-05	44	137	5	IPR002957
Domain	Beta-TrCP_D	BTRC FBXW11	5.34e-05	2	137	2	IPR021977
Domain	Beta-TrCP_D	BTRC FBXW11	5.34e-05	2	137	2	PF12125
Domain	Beta-TrCP_D	BTRC FBXW11	5.34e-05	2	137	2	SM01028
Domain	Intermediate_filament_CS	VIM KRT14 KRT17 KRT24 PRPH	9.86e-05	63	137	5	IPR018039
Domain	Myosin_head_motor_dom	MYH4 MYH6 MYH7 MYH8	1.69e-04	38	137	4	IPR001609
Domain	MYOSIN_MOTOR	MYH4 MYH6 MYH7 MYH8	1.69e-04	38	137	4	PS51456
Domain	Myosin_head	MYH4 MYH6 MYH7 MYH8	1.69e-04	38	137	4	PF00063
Domain	MYSc	MYH4 MYH6 MYH7 MYH8	1.69e-04	38	137	4	SM00242
Domain	Filament	VIM KRT14 KRT17 KRT24 PRPH	1.74e-04	71	137	5	SM01391
Domain	IF	VIM KRT14 KRT17 KRT24 PRPH	1.86e-04	72	137	5	PS00226
Domain	Filament	VIM KRT14 KRT17 KRT24 PRPH	1.99e-04	73	137	5	PF00038
Domain	ARM-type_fold	APC2 VEPH1 RYR3 DNAAF5 KIFAP3 RNPEP PIK3C2A VPS35 LTA4H FMNL1	2.03e-04	339	137	10	IPR016024
Domain	IF	VIM KRT14 KRT17 KRT24 PRPH	2.40e-04	76	137	5	IPR001664
Domain	Peptidase_M1_C	RNPEP LTA4H	3.17e-04	4	137	2	IPR015211
Domain	Leuk-A4-hydro_C	RNPEP LTA4H	3.17e-04	4	137	2	SM01263
Domain	Leuk-A4-hydro_C	RNPEP LTA4H	3.17e-04	4	137	2	PF09127
Domain	IQ	MYH4 MYH6 MYH7 MYH8 LRRIQ1	3.23e-04	81	137	5	SM00015
Domain	IQ_motif_EF-hand-BS	MYH4 MYH6 MYH7 MYH8 LRRIQ1	5.26e-04	90	137	5	IPR000048
Domain	IQ	MYH4 MYH6 MYH7 MYH8 LRRIQ1	6.12e-04	93	137	5	PS50096
Domain	EPTP	LGI2 LGI1	7.86e-04	6	137	2	PF03736
Domain	EPTP	LGI2 LGI1	7.86e-04	6	137	2	IPR005492
Domain	Filament_head	VIM PRPH	1.09e-03	7	137	2	PF04732
Domain	EAR	LGI2 LGI1	1.09e-03	7	137	2	IPR009039
Domain	EAR	LGI2 LGI1	1.09e-03	7	137	2	PS50912
Domain	Intermed_filament_DNA-bd	VIM PRPH	1.09e-03	7	137	2	IPR006821
Domain	Villin/Gelsolin	FLII SCIN	1.45e-03	8	137	2	IPR007122
Domain	S15_NS1_RNA-bd	EPRS1 TACC1	1.45e-03	8	137	2	IPR009068
Domain	GEL	FLII SCIN	1.45e-03	8	137	2	SM00262
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	VIM EPRS1 MAP9 MYH4 MYH6 MYH7 MYH8 KRT14 KRT17 CALD1 SPTA1 TAF1B RCN1 ZNF318 NEB LCP1 SKI TFAM ACTR3 ZC3H7A USP8 SETD5 FAM186A VPS35 EEA1 ARHGAP21 GOLGB1 PRPH	5.55e-12	1442	142	28	35575683
Pubmed	Diversity in transcriptional start site selection and alternative splicing affects the 5'-UTR of mouse striated muscle myosin transcripts.	MYH4 MYH6 MYH7 MYH8	9.23e-09	7	142	4	16819597
Pubmed	Genes for skeletal muscle myosin heavy chains are clustered and are not located on the same mouse chromosome as a cardiac myosin heavy chain gene.	MYH4 MYH6 MYH7 MYH8	1.84e-08	8	142	4	3864153
Pubmed	Single-Cell Lineage Tracing Reveals that Oriented Cell Division Contributes to Trabecular Morphogenesis and Regional Specification.	MYH6 MYH7 PECAM1 CDH2	5.49e-08	10	142	4	27052172
Pubmed	The mesenchymal property of mouse mammary anlagen repopulating cell population is associated with its stemness.	VIM KRT14 CDH2	2.66e-07	4	142	3	33132190
Pubmed	Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development.	MYH4 MYH7 MYH8	6.62e-07	5	142	3	12919077
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	VIM FLII EPRS1 TTF2 TAF1B DHX38 LARS1 CHD7 RBM28 TFAM ACTR3 KIF20B ZC3H7A AP2S1 PIK3C2A SERPINB3 VPS35 DDX60L YME1L1 BTRC	6.73e-07	1353	142	20	29467282
Pubmed	Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis.	VIM MYH7 MYH8 PECAM1	1.23e-06	20	142	4	22267199
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	LDLRAP1 VIM FLII EPRS1 SPAST APC2 LARS1 ANKRD49 SMG5 DSCAML1 ZNF181 RYR3 USP8 ZNF439 YME1L1 ARHGAP21 BTRC FBXW11 LGI1	1.31e-06	1285	142	19	35914814
Pubmed	Distinct myogenic programs of embryonic and fetal mouse muscle cells: expression of the perinatal myosin heavy chain isoform in vitro.	MYH4 MYH7 MYH8	1.32e-06	6	142	3	1728586
Pubmed	Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development.	MYH4 MYH7 MYH8	1.32e-06	6	142	3	10588881
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	VIM EPRS1 TTF2 CALD1 DHX38 LARS1 ZNF318 USP8 CCDC124 R3HCC1L LTA4H TACC1 SCIN HERC4 ARHGAP21 GOLGB1	1.49e-06	934	142	16	33916271
Pubmed	Prokineticin receptor-1 signaling promotes Epicardial to Mesenchymal Transition during heart development.	VIM MYH6 MYH7 PECAM1	1.51e-06	21	142	4	27150455
Pubmed	SEMA6A drives GnRH neuron-dependent puberty onset by tuning median eminence vascular permeability.	VIM PDGFRA PECAM1 PRPH	1.51e-06	21	142	4	38062045
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	VIM FLII EPRS1 MAP9 MYH6 KRT14 HSP90B2P CALD1 SPTA1 LARS1 TFAM ACTR3 PGM1 SACM1L AP2S1 RNPEP VPS35 CDH2 ARHGAP21 LGI1	1.59e-06	1431	142	20	37142655
Pubmed	Platelet-derived growth factor receptor beta signaling is required for efficient epicardial cell migration and development of two distinct coronary vascular smooth muscle cell populations.	VIM PDGFRA PECAM1	2.30e-06	7	142	3	18948621
Pubmed	A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.	MYH4 MYH7 MYH8	2.30e-06	7	142	3	35210422
Pubmed	The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development.	MYH6 MYH7 PECAM1 CDH2	2.66e-06	24	142	4	10021345
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	VIM FLII EPRS1 MYH4 MYH6 MYH7 MYH8 RCN1 ACTR3 SACM1L IL1R2 PRPF39 YME1L1	2.75e-06	647	142	13	26618866
Pubmed	Progressive reactive lymphoid connective tissue disease and development of autoantibodies in scavenger receptor A5-deficient mice.	VIM PDGFRA PECAM1	3.68e-06	8	142	3	23499552
Pubmed	Prrx1 marks stem cells for bone, white adipose tissue and dermis in adult mice.	VIM PDGFRA PECAM1	3.68e-06	8	142	3	36456880
Pubmed	A threshold of GATA4 and GATA6 expression is required for cardiovascular development.	MYH6 MYH7 PECAM1	3.68e-06	8	142	3	16847256
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	FLII EPRS1 KRT14 KRT17 CALD1 LARS1 RCN1 ZNF318 RBM28 F5 TFAM ACTR3 TBK1 EEA1 SCIN GOLGB1	4.82e-06	1024	142	16	24711643
Pubmed	Developmental changes of cell adhesion molecule expression in the fetal mouse liver.	VIM PECAM1 CDH2	5.50e-06	9	142	3	20687112
Pubmed	The expression of myosin genes in developing skeletal muscle in the mouse embryo.	MYH4 MYH7 MYH8	7.83e-06	10	142	3	2211821
Pubmed	Genetic Tracing Identifies Early Segregation of the Cardiomyocyte and Nonmyocyte Lineages.	MYH6 PDGFRA PECAM1	7.83e-06	10	142	3	31185811
Pubmed	NAK is recruited to the TNFR1 complex in a TNFalpha-dependent manner and mediates the production of RANTES: identification of endogenous TNFR-interacting proteins by a proteomic approach.	TBK1 BTRC FBXW11	7.83e-06	10	142	3	15485837
Pubmed	A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.	MRC1 TFAM KIF20B R3HCC1L DHTKD1 YME1L1 HERC4 ARHGAP21 BTRC LGI1	8.61e-06	415	142	10	16385451
Pubmed	HOXA5 Participates in Brown Adipose Tissue and Epaxial Skeletal Muscle Patterning and in Brown Adipocyte Differentiation.	MYH4 MYH8 PDGFRA NNMT	8.76e-06	32	142	4	33732701
Pubmed	Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.	VIM EPRS1 KRT14 KRT17 LARS1 ACTR3 PGM1 RNPEP VPS35 YME1L1	9.96e-06	422	142	10	27342126
Pubmed	Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscle.	MYH4 MYH7 PECAM1	1.07e-05	11	142	3	18310078
Pubmed	Mesenchymal cell replacement corrects thymic hypoplasia in murine models of 22q11.2 deletion syndrome.	KRT14 PDGFRA PECAM1	1.07e-05	11	142	3	36136514
Pubmed	Phf14, a novel regulator of mesenchyme growth via platelet-derived growth factor (PDGF) receptor-α.	VIM PDGFRA PECAM1	1.07e-05	11	142	3	22730381
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	VIM FLII SPTA1 APC2 ACTR3 AP2S1 NLGN2 CDH2 ARHGAP21 PRPH	1.17e-05	430	142	10	32581705
Pubmed	Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing.	VIM NMNAT1 ASAP3 NCF2 RBM28 ZC4H2 KIFAP3 TACC1 MAPK13 L3MBTL3 BTRC GABRA2 LGI1	1.19e-05	742	142	13	26871637
Pubmed	The loop-tail mouse model displays open and closed caudal neural tube defects.	VIM PDGFRA CDH2	1.43e-05	12	142	3	37589570
Pubmed	Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin.	VIM MYH6 MYH7	1.43e-05	12	142	3	8424456
Pubmed	The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint.	FBXO5 BTRC FBXW11	1.43e-05	12	142	3	18662541
Pubmed	Creation of bladder assembloids mimicking tissue regeneration and cancer.	VIM KRT14 PECAM1	1.43e-05	12	142	3	33328632
Pubmed	Cell diversity and plasticity during atrioventricular heart valve EMTs.	VIM PDGFRA PECAM1	1.43e-05	12	142	3	37689753
Pubmed	Reversible epigenetic modifications of the two cardiac myosin heavy chain genes during changes in expression.	MYH6 MYH7	1.66e-05	2	142	2	21526716
Pubmed	BerEp4, cytokeratin 14, and cytokeratin 17 immunohistochemical staining aid in differentiation of basaloid squamous cell carcinoma from basal cell carcinoma with squamous metaplasia.	KRT14 KRT17	1.66e-05	2	142	2	24168496
Pubmed	Length-dependent effects on cardiac contractile dynamics are different in cardiac muscle containing α- or β-myosin heavy chain.	MYH4 MYH7	1.66e-05	2	142	2	23111184
Pubmed	Characterization of human cardiac myosin heavy chain genes.	MYH6 MYH7	1.66e-05	2	142	2	2726733
Pubmed	Proposed structural models of human factor Va and prothrombinase.	F5 F10	1.66e-05	2	142	2	17973648
Pubmed	Human cardiac myosin heavy chain genes and their linkage in the genome.	MYH6 MYH7	1.66e-05	2	142	2	3037493
Pubmed	β-myosin heavy chain is induced by pressure overload in a minor subpopulation of smaller mouse cardiac myocytes.	MYH6 MYH7	1.66e-05	2	142	2	21778428
Pubmed	Similarity of molecular phenotype between known epilepsy gene LGI1 and disease candidate gene LGI2.	LGI2 LGI1	1.66e-05	2	142	2	20863412
Pubmed	Structural organization of the human cardiac alpha-myosin heavy chain gene (MYH6).	MYH6 MYH7	1.66e-05	2	142	2	8307559
Pubmed	Vimentin regulates differentiation switch via modulation of keratin 14 levels and their expression together correlates with poor prognosis in oral cancer patients.	VIM KRT14	1.66e-05	2	142	2	28225793
Pubmed	Prothrombinase complex assembly. Contributions of protein-protein and protein-membrane interactions toward complex formation.	F5 F10	1.66e-05	2	142	2	2303476
Pubmed	The critical role of the 185-189-loop in the factor Xa interaction with Na+ and factor Va in the prothrombinase complex.	F5 F10	1.66e-05	2	142	2	15347660
Pubmed	Molecular cloning and characterization of human cardiac alpha- and beta-form myosin heavy chain complementary DNA clones. Regulation of expression during development and pressure overload in human atrium.	MYH6 MYH7	1.66e-05	2	142	2	2969919
Pubmed	Selective regulation of Notch ligands during angiogenesis is mediated by vimentin.	VIM PECAM1	1.66e-05	2	142	2	28533359
Pubmed	Distribution and structure-function relationship of myosin heavy chain isoforms in the adult mouse heart.	MYH6 MYH7	1.66e-05	2	142	2	17575272
Pubmed	Mapping of the factor Xa binding site on factor Va by site-directed mutagenesis.	F5 F10	1.66e-05	2	142	2	18502757
Pubmed	Activation-dependent exposure of the inter-EGF sequence Leu83-Leu88 in factor Xa mediates ligand binding to effector cell protease receptor-1.	F5 F10	1.66e-05	2	142	2	9079657
Pubmed	Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene.	MYH6 MYH7	1.66e-05	2	142	2	9884344
Pubmed	Role of microtubules versus myosin heavy chain isoforms in contractile dysfunction of hypertrophied murine cardiocytes.	MYH6 MYH7	1.66e-05	2	142	2	12750067
Pubmed	Three cDNA sequences of mouse type I keratins. Cellular localization of the mRNAs in normal and hyperproliferative tissues.	KRT14 KRT17	1.66e-05	2	142	2	2433272
Pubmed	Transgenic mouse α- and β-cardiac myosins containing the R403Q mutation show isoform-dependent transient kinetic differences.	MYH6 MYH7	1.66e-05	2	142	2	23580644
Pubmed	Cofactor proteins in the assembly and expression of blood clotting enzyme complexes.	F5 F10	1.66e-05	2	142	2	3052293
Pubmed	β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations.	MYH6 MYH7	1.66e-05	2	142	2	24829265
Pubmed	Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart.	MYH6 MYH7	1.66e-05	2	142	2	2036722
Pubmed	Ensemble force changes that result from human cardiac myosin mutations and a small-molecule effector.	MYH6 MYH7	1.66e-05	2	142	2	25937279
Pubmed	Identification of a binding site for blood coagulation factor Xa on the heavy chain of factor Va. Amino acid residues 323-331 of factor V represent an interactive site for activated factor X.	F5 F10	1.66e-05	2	142	2	12379114
Pubmed	Blood coagulation and fibrinolysis in male patients with hypogonadotropic hypogonadism: plasma factor V and factor X activities increase in hypogonadotropic hypogonadism.	F5 F10	1.66e-05	2	142	2	18591887
Pubmed	Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage site.	F5 F10	1.66e-05	2	142	2	17553804
Pubmed	Contribution of amino acid region 659-663 of Factor Va heavy chain to the activity of factor Xa within prothrombinase .	F5 F10	1.66e-05	2	142	2	20722419
Pubmed	Myocardial contraction is 5-fold more economical in ventricular than in atrial human tissue.	MYH6 MYH7	1.66e-05	2	142	2	15621050
Pubmed	Genetic modification of survival in tissue-specific knockout mice with mitochondrial cardiomyopathy.	MYH6 TFAM	1.66e-05	2	142	2	10737799
Pubmed	Phosphatidylserine and FVa regulate FXa structure.	F5 F10	1.66e-05	2	142	2	24467409
Pubmed	Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone.	MYH6 MYH7	1.66e-05	2	142	2	18480046
Pubmed	Murine pulmonary myocardium: developmental analysis of cardiac gene expression.	MYH6 MYH7	1.66e-05	2	142	2	7919499
Pubmed	Phosphatidylserine-induced factor Xa dimerization and binding to factor Va are competing processes in solution.	F5 F10	1.66e-05	2	142	2	23214401
Pubmed	The characteristics and roles of β-TrCP1/2 in carcinogenesis.	BTRC FBXW11	1.66e-05	2	142	2	33021036
Pubmed	Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase.	F5 F10	1.66e-05	2	142	2	21071689
Pubmed	Long-Read Sequence Confirmed a Large Deletion Including MYH6 and MYH7 in an Infant of Atrial Septal Defect and Atrial Arrhythmias.	MYH6 MYH7	1.66e-05	2	142	2	34384224
Pubmed	βTrCP controls GH receptor degradation via two different motifs.	GHR BTRC	1.66e-05	2	142	2	22034227
Pubmed	Human cardiac myosin heavy chain gene mapped within chromosome region 14q11.2----q13.	MYH6 MYH7	1.66e-05	2	142	2	2494889
Pubmed	Factor Xa dimerization competes with prothrombinase complex formation on platelet-like membrane surfaces.	F5 F10	1.66e-05	2	142	2	25572019
Pubmed	Five skeletal myosin heavy chain genes are organized as a multigene complex in the human genome.	MYH4 MYH8	1.66e-05	2	142	2	8518795
Pubmed	Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin.	KRT14 KRT17	1.66e-05	2	142	2	20871598
Pubmed	Screening diagnostic biomarkers of OSCC via an LCM-based proteomic approach.	KRT14 KRT17	1.66e-05	2	142	2	30066921
Pubmed	All-atom molecular dynamics simulations of actin-myosin interactions: a comparative study of cardiac α myosin, β myosin, and fast skeletal muscle myosin.	MYH6 MYH7	1.66e-05	2	142	2	24224850
Pubmed	ADPEAF mutations reduce levels of secreted LGI1, a putative tumor suppressor protein linked to epilepsy.	LGI2 LGI1	1.66e-05	2	142	2	15857855
Pubmed	Myosin heavy chain composition and the economy of contraction in healthy and diseased human myocardium.	MYH6 MYH7	1.66e-05	2	142	2	16088376
Pubmed	Complete sequence of human cardiac alpha-myosin heavy chain gene and amino acid comparison to other myosins based on structural and functional differences.	MYH6 MYH7	1.66e-05	2	142	2	1776652
Pubmed	Specificity, location and function of βTrCP isoforms and their splice variants.	BTRC FBXW11	1.66e-05	2	142	2	21138764
Pubmed	PI3KC2α, a class II PI3K, is required for dynamin-independent internalization pathways.	PIK3C2A EEA1	1.66e-05	2	142	2	21081650
Pubmed	Cooperative regulation of the activity of factor Xa within prothrombinase by discrete amino acid regions from factor Va heavy chain.	F5 F10	1.66e-05	2	142	2	18991406
Pubmed	Refined mapping of Naegeli-Franceschetti- Jadassohn syndrome to a 6 cM interval on chromosome 17q11.2-q21 and investigation of candidate genes.	KRT14 KRT24	1.66e-05	2	142	2	12230514
Pubmed	Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.	MYH6 MYH7	1.66e-05	2	142	2	9541509
Pubmed	Differential dysregulation of β-TrCP1 and -2 by HIV-1 Vpu leads to inhibition of canonical and non-canonical NF-κB pathways in infected cells.	BTRC FBXW11	1.66e-05	2	142	2	37341489
Pubmed	The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.	F5 F10	1.66e-05	2	142	2	15641797
Pubmed	Epithelial cell migration requires the interaction between the vimentin and keratin intermediate filaments.	VIM KRT14	1.66e-05	2	142	2	27072292
Pubmed	Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles.	MYH4 MYH7 MYH8	1.85e-05	13	142	3	8404542
Pubmed	Brg1 governs distinct pathways to direct multiple aspects of mammalian neural crest cell development.	VIM PECAM1 CHD7	1.85e-05	13	142	3	23319608
Pubmed	Membrane β-catenin and adherens junctions in early gonadal patterning.	PDGFRA PECAM1 CDH2	2.35e-05	14	142	3	22972715
Pubmed	Stress-Induced Cyclin C Translocation Regulates Cardiac Mitochondrial Dynamics.	MYH6 MYH7 CCNC	2.35e-05	14	142	3	32248761
Interaction	CFTR interactions	VIM FLII EPRS1 EGLN3 MYH4 MYH6 MYH7 MYH8 KRT14 KRT17 CALD1 PDGFRA VEPH1 RCN1 ANKRD49 LCP1 ACTR3 RYR3 SACM1L KRT24 IL1R2 SERPINB3 SAMD3 EEA1 PRPF39 YME1L1	9.77e-06	1480	140	26	int:CFTR
Interaction	PRPH interactions	VIM KRT14 KRT17 ZC4H2 KRT24 TBK1 CDH2 ARHGAP21 PRPH	1.31e-05	204	140	9	int:PRPH
Interaction	TMOD1 interactions	FLII CALD1 NEB CEP152 TACC1 SCIN ARHGAP21 GOLGB1	1.70e-05	161	140	8	int:TMOD1
Interaction	APC interactions	EGLN3 KRT14 SPAST KRT17 APC2 NEB ACTR3 KIFAP3 AP2S1 ARHGAP21 BTRC FBXW11	1.79e-05	389	140	12	int:APC
Interaction	SIPA1L3 interactions	VIM EGLN3 CALD1 ACTR3 CEP152 FMNL1 PRPH	1.86e-05	118	140	7	int:SIPA1L3
Interaction	SMG5 interactions	FLII EGLN3 SMG5 ZC3H7A CEP152 BTRC	2.63e-05	84	140	6	int:SMG5
Interaction	STK3 interactions	EGLN3 MYH6 MYH7 MYH8 NEB ZC3H7A BTRC FBXW11	3.95e-05	181	140	8	int:STK3
Interaction	DSP interactions	VIM EPRS1 KRT14 KRT17 PECAM1 LARS1 CASP4 RYR3 USP8 CEP152 BTRC PRPH	4.06e-05	423	140	12	int:DSP
Interaction	KRT72 interactions	VIM KRT14 KRT17 KRT24 PRPH	5.58e-05	59	140	5	int:KRT72
Cytoband	17p13.1	MYH4 MYH8 RCVRN NLGN2 KCNAB3	3.49e-05	118	142	5	17p13.1
GeneFamily	Myosin heavy chains	MYH4 MYH6 MYH7 MYH8	6.26e-07	15	86	4	1098
GeneFamily	Intermediate filaments Type III	VIM PRPH	2.22e-04	5	86	2	610
GeneFamily	Keratins, type I	KRT14 KRT17 KRT24	3.12e-04	28	86	3	608
GeneFamily	Gelsolin/villins	FLII SCIN	6.15e-04	8	86	2	950
GeneFamily	EF-hand domain containing	SPTA1 RCN1 RCVRN LCP1 TBC1D8B RYR3	6.19e-04	219	86	6	863
GeneFamily	WD repeat domain containing\|F-box and WD repeat domain containing	BTRC FBXW11	1.20e-03	11	86	2	559
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PSD2 VEPH1 ASAP3 ARHGAP25 ARHGAP21	3.02e-03	206	86	5	682
GeneFamily	Aminoacyl tRNA synthetases, Class I	EPRS1 LARS1	3.63e-03	19	86	2	131
Coexpression	LIM_MAMMARY_STEM_CELL_UP	VIM KRT14 PSD2 ARHGEF28 CALD1 SKI ARC ARHGAP25 TACC1 NLGN2 NNMT DCBLD2	1.23e-05	479	142	12	M2573
Coexpression	LIM_MAMMARY_STEM_CELL_UP	VIM KRT14 PSD2 ARHGEF28 CALD1 SKI ARC ARHGAP25 TACC1 NLGN2 NNMT DCBLD2	1.34e-05	483	142	12	MM1082
Coexpression	GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP	MYH8 TEX2 RYR3 CCNC DNAAF5 EEA1 CMTR2 HCCS	1.35e-05	199	142	8	M7274
Coexpression	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP	EPRS1 EGLN3 LCP1 PGM1	3.37e-05	34	142	4	M1313
Coexpression	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP	EPRS1 EGLN3 LCP1 PGM1	4.75e-05	37	142	4	MM549
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	EPRS1 TTF2 PSPH TFAM KIF20B ZC3H7A AP2S1 FBXO5 CCDC34 VPS35 YME1L1 HERC4 HCCS	5.06e-05	644	142	13	M10501
Coexpression	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	CASP4 USP8 FBXO5 TACC1 YME1L1	8.49e-05	82	142	5	M9224
Coexpression	GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_DN	LDLRAP1 PECAM1 ZNF318 LCP1 TFAM FAM186A EEA1	1.10e-04	199	142	7	M9543
Coexpression	GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP	NMNAT1 CCNC KIFAP3 GLMN SLC4A1AP NLGN2 FBXW11	1.13e-04	200	142	7	M7077
Coexpression	GSE18893_TCONV_VS_TREG_2H_CULTURE_DN	LDLRAP1 VIM SPAST CHD7 NEB PIK3C2A KCNAB3	1.13e-04	200	142	7	M7293
Coexpression	GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN	CASP4 CHRNA3 IL1R2 ARC EEA1 FBXW11 LGI1	1.13e-04	200	142	7	M9755
Coexpression	GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN	MYH7 SCAF8 CASP4 PSPH METTL6 EEA1 GOLGB1	1.13e-04	200	142	7	M7418
Coexpression	GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_DN	GBP6 ARHGEF28 PSPH LCP1 GHR KLHL11 RNPEP	1.13e-04	200	142	7	M5094
Coexpression	HALLMARK_MTORC1_SIGNALING	EPRS1 EGLN3 PSPH ACTR3 PGM1 TBK1 LTA4H	1.13e-04	200	142	7	M5924
Coexpression	GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_UP	SCAF8 TAF1B RCN1 CASP4 LCP1 SKI HERC4	1.13e-04	200	142	7	M6953
ToppCell	Children_(3_yrs)-Immune\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VIM MRC1 NCF2 LCP1 ACTR3 ARHGAP25 DDX60L FMNL1	2.38e-07	197	142	8	f18807124b91310fcd84238484a80ecdba684679
ToppCell	LPS_IL1RA-Hematopoietic_Myeloid-Monocytes,_Macrophages\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	VIM MRC1 CASP4 NCF2 LCP1 ACTR3 AP2S1 FMNL1	2.47e-07	198	142	8	7490b30462d03b5edee3bcacdef9483dd15821b5
ToppCell	LPS_IL1RA-Hematopoietic_Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	VIM MRC1 CASP4 NCF2 LCP1 ACTR3 AP2S1 FMNL1	2.47e-07	198	142	8	4f86ff6ba8cbe987e7541fca4f3ae8d0e434677d
ToppCell	5'-Adult-Distal_Rectal-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VIM MRC1 TEX2 NCF2 NEB IL1R2 FMNL1	1.41e-06	173	142	7	b335ca2a247156eba821943b2b9fc9922230b409
ToppCell	FLU-Healthy-5\|Healthy / Virus stimulation, Condition and Cluster	NCF2 PSPH KIF20B IL1R2 MAPK13 ARHGAP21 IL9R	1.41e-06	173	142	7	8c218ec1ba927e9312f3df5f312395e907ab64ab
ToppCell	FLU-Healthy-5\|FLU / Virus stimulation, Condition and Cluster	NCF2 PSPH KIF20B IL1R2 MAPK13 ARHGAP21 IL9R	1.41e-06	173	142	7	bd4f06d971f9d138749094047c9337dfbaf5da31
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH6 MYH7 SLC9C1 DDX60L ADPRHL1 CDH2 DCBLD2	1.59e-06	176	142	7	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	MYH4 MYH8 CCDC178 SCIN CNGA3	1.63e-06	62	142	5	a20620a8869721ea62984c2022ee1b484b455824
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	MYH4 MYH8 CCDC178 SCIN CNGA3	1.63e-06	62	142	5	ee694c06bcd924b4ddf744178ba3a99e04eed51b
ToppCell	356C-Fibroblasts-Fibroblast-E-\|356C / Donor, Lineage, Cell class and subclass (all cells)	CALD1 PDGFRA AOX1 NEB NAALADL2 F10 FAM186A	1.71e-06	178	142	7	a493a277d175e5e153410a745b26ebe2e0839ea0
ToppCell	356C-Fibroblasts-Fibroblast-E\|356C / Donor, Lineage, Cell class and subclass (all cells)	CALD1 PDGFRA AOX1 NEB NAALADL2 F10 FAM186A	1.71e-06	178	142	7	371218babddfd3d8a7bb82a46ce65327ee3fcf12
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC1 TTF2 KBTBD8 F10 KIF20B FBXO5 CEP152	1.98e-06	182	142	7	21dcab170ffeef89faa9fee5008568cb6e15c694
ToppCell	21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high\|Trachea / Age, Tissue, Lineage and Cell class	CALD1 PDGFRA AOX1 F10 LGI2 NNMT PRPH	1.98e-06	182	142	7	354dcdb01360597f68c4fe157a682aee1c0b8bb1
ToppCell	Macrophages-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	MRC1 ARHGEF28 PECAM1 NCF2 LCP1 DDX60L FMNL1	2.55e-06	189	142	7	c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Nptx2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	EGLN3 CCDC178 TBC1D8B CHRNA3 NNMT PRPH	2.66e-06	122	142	6	1720756e0b3e8db14a9ccabe83f9b41689a4f754
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EGLN3 KRT17 TAF1B CCDC178 SERPINB3 CMTR2 DCBLD2	3.02e-06	194	142	7	0e9830ad070c47acaa952400bf2a3ddbff664a2f
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PRUNE2 MAP9 EGLN3 CALD1 COX16 EEA1 GOLGB1	3.02e-06	194	142	7	8985095f291c1b54e45f4edece49aa26e8c8b732
ToppCell	18-Airway-Epithelial-Epithelial\|Airway / Age, Tissue, Lineage and Cell class	PRUNE2 APC2 CHRNA3 CDH2 GABRA2 LGI1 PRPH	3.02e-06	194	142	7	d3c90e1f1228f8ba0ba56105c6cf4f302c388f28
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP9 CALD1 PDGFRA COX16 RBM28 RYR3 EEA1	3.13e-06	195	142	7	32ec72103faccc9e37c0ecedff1998e7df6a19f6
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ARHGEF28 AOX1 NAALADL2 F5 RYR3 IL1R2 LGI1	3.13e-06	195	142	7	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ARHGEF28 AOX1 NAALADL2 F5 RYR3 IL1R2 LGI1	3.13e-06	195	142	7	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	VIM MRC1 NCF2 LCP1 ACTR3 AP2S1 FMNL1	3.46e-06	198	142	7	57cfc1cc8b332a88e7cac7f6f042b3ffd498a1b9
ToppCell	Adult-Immune\|Adult / Lineage, Cell type, age group and donor	VIM MRC1 NCF2 LCP1 ARHGAP25 DDX60L FMNL1	3.46e-06	198	142	7	9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Myeloid-Monocytes,_Macrophages\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	VIM MRC1 NCF2 LCP1 ACTR3 AP2S1 FMNL1	3.46e-06	198	142	7	c3949970cfe0cb928293ad6627aeed3ed2741b95
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CALD1 PDGFRA RCN1 GHR SCIN NNMT CDH2	3.46e-06	198	142	7	9d61483b0decac2fe90045b3474843360b2c49b3
ToppCell	Transplant_Alveoli_and_parenchyma\|World / Tissue, Lineage and Cell class of Lung Cells from 10X	VIM MRC1 PECAM1 NCF2 LCP1 LTA4H NNMT	3.58e-06	199	142	7	44bd36a62f06058c5d09feec6e96ecaf310f4791
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	VIM MRC1 NCF2 AP2S1 IL1R2 LTA4H DDX60L	3.58e-06	199	142	7	a1ff1063741f6e5569feb44245785c9f472799b2
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VIM CALD1 PDGFRA AOX1 GHR TACC1 NNMT	3.70e-06	200	142	7	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VIM CALD1 PDGFRA AOX1 GHR TACC1 NNMT	3.70e-06	200	142	7	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VIM CALD1 PDGFRA AOX1 F10 KRT24 NNMT	3.70e-06	200	142	7	f6cf98aad53aa8b3fa02cf874d6f7cd75530a213
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF28 F5 CFAP65 DNAAF5 IL1R2 LTA4H	4.38e-06	133	142	6	292ecfcadbaf15e0d34a3ab9bf511ab1065888bd
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF28 F5 CFAP65 DNAAF5 IL1R2 LTA4H	4.38e-06	133	142	6	f6e9a1301a3379847b215303a9b0c028841e2cc0
ToppCell	ASK440-Epithelial-Secretory\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	VIM MRC1 KRT17 NCF2 LCP1 SERPINB3	6.39e-06	142	142	6	ea694a907eaa46c55665692cb830870281700e40
ToppCell	LPS-antiTNF-Unknown-Endothelial-Monocytes-Macrophages\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPAST LCP1 KIF20B IL1R2 CEP152 MAPK13	6.39e-06	142	142	6	b66f9602dba30d1d4fbcc49ceb112eb5bd916ba1
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-Naive_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	MAP9 PECAM1 ASAP3 DSCAML1 ARC PGBD4	1.06e-05	155	142	6	1020da8a2c30384d962fa204a030299fdfcbbf98
ToppCell	facs-Heart-RA-24m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH6 MYH7 KRT14 RYR3 IL1R2 ADPRHL1	1.14e-05	157	142	6	9021900d9b1a71210c9c414a9d165eaf399eb607
ToppCell	facs-Heart-RA-24m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH6 MYH7 KRT14 RYR3 IL1R2 ADPRHL1	1.14e-05	157	142	6	c8c627ca181856cd31dba4cf073c2be659a49dc1
ToppCell	facs-Lung-EPCAM-3m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH4 NCF2 LCP1 F5 IL1R2 HERC4	1.26e-05	160	142	6	b88876a58fea2066468e74dcc439c8561130a910
ToppCell	facs-Lung-EPCAM-3m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH4 NCF2 LCP1 F5 IL1R2 HERC4	1.26e-05	160	142	6	b73f07a0088936fbc3656a05710a67f38b4ae551
ToppCell	PND01-Immune-Immune_Myeloid\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC1 NCF2 LCP1 F10 IL1R2 FMNL1	1.40e-05	163	142	6	ca12d01615be371fe215ec673d4ec787381e0ca6
ToppCell	PND01-Immune\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC1 NCF2 LCP1 F10 IL1R2 FMNL1	1.40e-05	163	142	6	98af13bd4257a9da325e1ffe5a254f0f58ca6c4b
ToppCell	facs-Heart-LV-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH8 SPTA1 FBXO5 IL1R2 CEP152 ADPRHL1	1.51e-05	165	142	6	84eca6a0f5e996b6955ae79fa102af239098fe8f
ToppCell	facs-Heart-LV-3m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH8 SPTA1 FBXO5 IL1R2 CEP152 ADPRHL1	1.51e-05	165	142	6	af59a095ecc6758abc13d763c00e44447c488167
ToppCell	facs-MAT-Fat-18m-Myeloid\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 NCF2 LCP1 F10 IL1R2 FMNL1	1.56e-05	166	142	6	9116be2805c34881debb999d8417e43832fcf2f2
ToppCell	facs-MAT-Fat-18m-Myeloid-nan\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 NCF2 LCP1 F10 IL1R2 FMNL1	1.56e-05	166	142	6	5c2667da79935f3d4b1edbfe7a10e7dbc2fa3ad0
ToppCell	facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COX16 NCF2 NEB F5 F10 R3HCC1L	1.72e-05	169	142	6	813472d429c0b12580b17b440e00a6d8beb7947f
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC1 TTF2 LCP1 KIF20B FBXO5 CCDC34	1.84e-05	171	142	6	845f312f8cbe29d820da25f0e6d75deb382bbfd8
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CALD1 PDGFRA ASAP3 RCN1 PSPH PRPH	2.10e-05	175	142	6	e99e145a152f534b75267ec492a252a0b814b4f8
ToppCell	droplet-Marrow-nan-21m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCF2 LCP1 ACTR3 IL1R2 LTA4H MAPK13	2.17e-05	176	142	6	f7d8eb90489a6d22240179abeb0aa16ac24615d3
ToppCell	356C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	KRT17 CALD1 PDGFRA GHR NNMT CDH2	2.17e-05	176	142	6	2287bd8382f41e36ebb0875a0133bada1ec81fa7
ToppCell	356C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)\|356C / Donor, Lineage, Cell class and subclass (all cells)	KRT17 CALD1 PDGFRA GHR NNMT CDH2	2.17e-05	176	142	6	135d51d28a7ad2a67d5a6c49eb6e661f4beb66f5
ToppCell	droplet-Lung\|droplet / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NCF2 LCP1 F10 ACTR3 AP2S1 FMNL1	2.24e-05	177	142	6	dd35d534ba09237a37ac58cca184e5d84d3b36ac
ToppCell	356C-Endothelial_cells-Endothelial-D-\|356C / Donor, Lineage, Cell class and subclass (all cells)	VIM CALD1 PECAM1 CCDC178 NNMT GABRA2	2.24e-05	177	142	6	ab8f09e118e4df696b0b4d33f013da020bdbd351
ToppCell	356C-Endothelial_cells-Endothelial-D\|356C / Donor, Lineage, Cell class and subclass (all cells)	VIM CALD1 PECAM1 CCDC178 NNMT GABRA2	2.24e-05	177	142	6	a0b172f40e0df97a288a5549ae7066697ad469b3
ToppCell	droplet-Lung\|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCF2 LCP1 F10 ACTR3 AP2S1 FMNL1	2.24e-05	177	142	6	e1555e45880c04fcc89e1234e97897d27246250f
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC1 NCF2 LCP1 F10 IL1R2 FMNL1	2.24e-05	177	142	6	1e7b4c0e41649d57a2c219a3b7e693538b8b34e4
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PPIL6 DSCAML1 AGBL3 LGI2 CDH2 GABRA2	2.31e-05	178	142	6	c20f050344a2e120e685e2a7fe36c6dfc1dc37b6
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MRC1 NCF2 RNPEP LTA4H DDX60L FMNL1	2.31e-05	178	142	6	0b398656f26c4061b11ccf98908d0e2e1367585a
ToppCell	3'-Adult-LargeIntestine-Epithelial-neuro-epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	F10 CFAP65 TEKT2 ARC MARCHF4 PRPH	2.38e-05	179	142	6	f93e81a3fd94adedb24a9db4ac1d53e275bbf8b5
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRUNE2 CALD1 PDGFRA AOX1 F10 CDH2	2.54e-05	181	142	6	eea943fdcbef0bbaa8578f3296923e874893b405
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRUNE2 CALD1 PDGFRA AOX1 F10 CDH2	2.54e-05	181	142	6	9c157de9d3403e092c907599f2a2c16db5b21131
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRUNE2 CALD1 PDGFRA AOX1 CDH2 KCNAB3	2.54e-05	181	142	6	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VIM MRC1 PECAM1 NCF2 LCP1 LTA4H	2.70e-05	183	142	6	103c4c4595d8daa677679fd2fa1e99cd398e56dd
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRUNE2 CALD1 PDGFRA AOX1 F10 CDH2	2.70e-05	183	142	6	bc7dd6a40ec9c773d005c1a46f305d40cdd0a326
ToppCell	3'-Adult-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	F10 CFAP65 TEKT2 ARC MARCHF4 PRPH	2.70e-05	183	142	6	49f3ddc1c7c04b4ca837dbd6dad995add82941d6
ToppCell	droplet-Marrow-nan-21m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VIM NCF2 LCP1 ACTR3 RNPEP LTA4H	3.05e-05	187	142	6	20b25b0d08550a1e8e997c5ce67d8e34bf7fc398
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	PRUNE2 MYH6 CALD1 NEB ADPRHL1 CDH2	3.14e-05	188	142	6	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	Epithelial-Epithelial-D_(Ciliated)\|Epithelial / shred on cell class and cell subclass (v4)	MAP9 PPIL6 CFAP65 TEKT2 LRRIQ1 CCDC34	3.14e-05	188	142	6	8f30535a32968a81a304315a49c0d90a77d36948
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARHGEF28 APC2 CHD7 CHRNA3 ARC PRPH	3.23e-05	189	142	6	3f5522be3e24dcdb6272f18cee2f239dfdeff9ad
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VIM CHIA CALD1 PECAM1 NNMT GOLGB1	3.33e-05	190	142	6	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	COVID-19-kidney-Proliferating_T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TTF2 SPTA1 LCP1 KIF20B FBXO5 CEP152	3.43e-05	191	142	6	bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCell	PSB-critical-LOC-Myeloid-Neutrophil\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	VIM NCF2 LCP1 IL1R2 DDX60L FMNL1	3.53e-05	192	142	6	8dbdaa6a81767a866fb856f99ae35f9ee8064106
ToppCell	11.5-Airway-Epithelial-Epithelial\|Airway / Age, Tissue, Lineage and Cell class	PRUNE2 APC2 CHRNA3 GABRA2 LGI1 PRPH	3.53e-05	192	142	6	a77d3692ff02ef7e066a9bd9e22725055a25c4d4
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	EPRS1 MAP9 SPAST KLHL11 USP8 PIK3C2A	3.64e-05	193	142	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARHGEF28 APC2 CHD7 CHRNA3 ARC PRPH	3.74e-05	194	142	6	5bd0f739aa75f387cca7c3b2686493ee2d1ee968
ToppCell	Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VIM MRC1 TEX2 NCF2 LTA4H DDX60L	3.74e-05	194	142	6	69cf7c989ac355c459db13f9d4267b55adc3c174
ToppCell	IPF-Myeloid\|IPF / Disease state, Lineage and Cell class	VIM MRC1 NCF2 LCP1 AP2S1 LTA4H	3.85e-05	195	142	6	fdeb958aeaa00f3fc25c4e59efbbc6f4a572c9ce
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	VIM NCF2 LCP1 IL1R2 DDX60L FMNL1	3.96e-05	196	142	6	6230b4a26770d30f1ab83345c087f03be1be0f9e
ToppCell	COVID-19-Myeloid-Monocytes\|COVID-19 / group, cell type (main and fine annotations)	PECAM1 NCF2 LCP1 IL1R2 LTA4H FMNL1	3.96e-05	196	142	6	04d710267658ea5601ae2cfb4ed5acb8a29bd8a1
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MRC1 CASP4 NCF2 LCP1 IL1R2 LTA4H	3.96e-05	196	142	6	f811958823380069077754283e36106d80147494
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CALD1 PDGFRA AOX1 F10 GHR NNMT	4.08e-05	197	142	6	3bb92dd8a94e2be3b7fe51c9a21b241215477ac7
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GBP6 KRT14 KRT17 KRT24 SERPINB3 TMPRSS11A	4.08e-05	197	142	6	61c0d78b29dc4ad8a84172cbfcdab03f31351d0e
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GBP6 KRT14 KRT17 KRT24 SERPINB3 TMPRSS11A	4.08e-05	197	142	6	dcabea5c50c133c9a4e294e447462d0393174ea7
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CASP4 NCF2 LCP1 IL1R2 DDX60L FMNL1	4.08e-05	197	142	6	340ce4fef244176fb52e38ffbcbdfda5ac3467dd
ToppCell	BL\|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NCF2 LCP1 ACTR3 IL1R2 DDX60L FMNL1	4.08e-05	197	142	6	1acf0191fa0a25cd20bfd9ea7bf727a1555986a1
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	CALD1 PDGFRA RCN1 SCIN NNMT CDH2	4.08e-05	197	142	6	63b63c6b2f842adb87bc83222ff86796bd9b58f6
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CALD1 PDGFRA AOX1 F10 GHR NNMT	4.08e-05	197	142	6	17344464fdcc5ba0c03959696b97c195f11e644c
ToppCell	URO-Myeloid-CD14_Mono\|URO / Disease, Lineage and Cell Type	VIM NCF2 LCP1 AP2S1 IL1R2 LTA4H	4.08e-05	197	142	6	45c16125fa32e50304fdd45a7cb457488bd50ee3
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GBP6 KRT14 KRT17 KRT24 SERPINB3 TMPRSS11A	4.08e-05	197	142	6	fb272c9c60ee3d980e528044dc567b4925a23da6
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KRT14 PSD2 KRT17 CALD1 RYR3 TACC1	4.08e-05	197	142	6	f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e
ToppCell	COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MRC1 NCF2 LCP1 IL1R2 ARHGAP25 FMNL1	4.08e-05	197	142	6	e42910a653a1b5bd90c090e9665a84871ed2873f
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VIM MRC1 NCF2 LCP1 AP2S1 LTA4H	4.08e-05	197	142	6	bf0f64bd356584cd4f8ac68867604c2118067450
ToppCell	5'-Adult-Appendix-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VIM CALD1 PDGFRA AOX1 ARC NNMT	4.08e-05	197	142	6	b11a5d909942a4299cbc0b27332b1a3f66f3bccd
ToppCell	COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi\|lung / Disease (COVID-19 only), tissue and cell type	MRC1 NCF2 LCP1 IL1R2 ARHGAP25 FMNL1	4.08e-05	197	142	6	3896729740d151f0eb845f1961c7b969bfbdd28d
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	CALD1 PDGFRA RCN1 SCIN NNMT CDH2	4.08e-05	197	142	6	fb50903b87498b400c8e16e6a561b6d9458e5d97
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CALD1 PDGFRA AOX1 F10 GHR NNMT	4.08e-05	197	142	6	5b8d0d7116b20d8e27541e88ec80c9f1f477e384
ToppCell	Control_saline-Epithelial_airway\|Control_saline / Treatment groups by lineage, cell group, cell type	PPIL6 CFAP65 TEKT2 KRT24 LRRIQ1 SCIN	4.19e-05	198	142	6	e6863238e022ecfb6a8e3f4b7661b376e92c5d8f
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GBP6 KRT14 KRT17 KRT24 SERPINB3 TMPRSS11A	4.19e-05	198	142	6	e06d41a7254a09e037ec404be2d8c352d5cbd7f4
ToppCell	NS-critical-LOC\|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	VIM CASP4 LCP1 IL1R2 ARHGAP25 DDX60L	4.19e-05	198	142	6	ff9b9065f5d91a7aff99121bddc3e86f6b1c8a8d
ToppCell	10x5'v1-week_14-16-Mesenchymal_myocytic\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CALD1 PDGFRA RCN1 GHR SCIN NNMT	4.19e-05	198	142	6	55d2ed345101bec4b73f1242ba8c4d73073b7e88
Drug	dicyclohexyl phthalate	VIM EPRS1 MYH4 KRT14 KRT17 CALD1 AOX1 RCN1 RCVRN LCP1 F10 ACTR3 PGM1 GHR GLMN RNPEP SERPINB3 ARC NNMT CDH2 LGI1	4.92e-08	836	141	21	ctd:C036042
Drug	oxovanadium	MYH4 MYH6 MYH7 MYH8 AOX1 KIFAP3 ARC LTA4H	8.31e-07	120	141	8	CID000024411
Drug	monomethyl phthalate	VIM MYH4 GBP6 KRT14 KRT17 CALD1 AOX1 RCN1 CHD7 LCP1 SKI F10 ACTR3 GHR ARC TACC1 EEA1 NNMT CDH2	7.33e-06	957	141	19	ctd:C517284
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH4 MYH6 MYH7 MYH8	9.69e-08	10	139	4	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH4 MYH6 MYH7 MYH8	9.69e-08	10	139	4	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH4 MYH6 MYH7 MYH8	9.69e-08	10	139	4	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH4 MYH6 MYH7 MYH8	9.69e-08	10	139	4	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH4 MYH6 MYH7 MYH8	9.69e-08	10	139	4	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH4 MYH6 MYH7 MYH8	9.69e-08	10	139	4	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH4 MYH6 MYH7 MYH8	9.69e-08	10	139	4	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH4 MYH6 MYH7 MYH8	9.69e-08	10	139	4	DOID:0080326 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH4 MYH6 MYH7 MYH8	2.27e-07	12	139	4	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH4 MYH6 MYH7 MYH8	2.27e-07	12	139	4	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH4 MYH6 MYH7 MYH8	3.26e-07	13	139	4	DOID:397 (implicated_via_orthology)
Disease	distal arthrogryposis (implicated_via_orthology)	MYH4 MYH6 MYH7 MYH8	6.18e-07	15	139	4	DOID:0050646 (implicated_via_orthology)
Disease	Abnormality of the eye	APC2 CDH2 FBXW11	3.53e-06	7	139	3	C4316870
Disease	hypereosinophilic syndrome (is_implicated_in)	PDGFRA F5	2.20e-05	2	139	2	DOID:999 (is_implicated_in)
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH4 MYH6 MYH7 MYH8 YME1L1	3.91e-05	80	139	5	DOID:12930 (implicated_via_orthology)
Disease	myopathy (implicated_via_orthology)	MYH4 MYH6 MYH7 MYH8	7.81e-05	48	139	4	DOID:423 (implicated_via_orthology)
Disease	prothrombin time measurement	TTF2 F5 F10	1.28e-04	21	139	3	EFO_0008390
Disease	Cardiomyopathy, Familial Hypertrophic, 1 (disorder)	MYH6 MYH7	1.31e-04	4	139	2	C3495498
Disease	Hypertrophic cardiomyopathy 1	MYH6 MYH7	1.31e-04	4	139	2	cv:C3495498
Disease	Caveolinopathy	MYH6 MYH7	1.31e-04	4	139	2	cv:C5679790
Disease	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH6 MYH7	1.31e-04	4	139	2	192600
Disease	Menkes disease (implicated_via_orthology)	BTRC FBXW11	2.18e-04	5	139	2	DOID:1838 (implicated_via_orthology)
Disease	varicose veins (is_marker_for)	VIM PECAM1	3.26e-04	6	139	2	DOID:799 (is_marker_for)
Disease	cardiomyopathy (implicated_via_orthology)	MYH4 MYH6 MYH7 MYH8	3.59e-04	71	139	4	DOID:0050700 (implicated_via_orthology)
Disease	Idiopathic hypertrophic subaortic stenosis	MYH6 MYH7	4.56e-04	7	139	2	C0700053
Disease	Obstructive asymmetric septal hypertrophy	MYH6 MYH7	4.56e-04	7	139	2	C0597124
Disease	Familial hypercholesterolemia	LDLRAP1 GHR	6.06e-04	8	139	2	cv:C0020445
Disease	Cardiomyopathy, Hypertrophic, Familial	MYH6 MYH7	7.76e-04	9	139	2	C0949658
Disease	Muscular dystrophy, limb-girdle, autosomal dominant	MYH6 MYH7	9.67e-04	10	139	2	cv:C5675009
Disease	sciatic neuropathy (biomarker_via_orthology)	MYH4 NMNAT1 PDGFRA NLGN2	1.26e-03	99	139	4	DOID:11446 (biomarker_via_orthology)
Disease	reticulocyte measurement	ARHGEF28 SPTA1 KBTBD8 PPIL6 LCP1 SKI F10 KLHL11 CCDC124 TBK1 ARHGAP25 L3MBTL3 ARHGAP21	1.46e-03	1053	139	13	EFO_0010700
Disease	Tobacco Dependence	LCP1 CHRNA3	1.93e-03	14	139	2	C0040332
Disease	Nicotine Dependence	LCP1 CHRNA3	1.93e-03	14	139	2	C0028043
Disease	Nicotine Use Disorder	LCP1 CHRNA3	1.93e-03	14	139	2	C0376384
Disease	peripheral arterial disease	LCP1 F5 CHRNA3	2.13e-03	54	139	3	EFO_0004265
Disease	dual specificity mitogen-activated protein kinase kinase 2 measurement	F10 ADPRHL1	2.53e-03	16	139	2	EFO_0008112
Disease	Blood Coagulation Disorders	F5 F10	2.53e-03	16	139	2	C0005779
Disease	Amyotrophic Lateral Sclerosis	ARHGEF28 TBK1 PRPH	2.61e-03	58	139	3	C0002736
Disease	Ischemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism	TTF2 F5	2.86e-03	17	139	2	EFO_0000712, EFO_0003827, EFO_0003907, EFO_0004286, HP_0001977, HP_0002140
Disease	Global developmental delay	APC2 CDH2 FBXW11 GABRA2	3.67e-03	133	139	4	C0557874
Disease	Liver Cirrhosis, Experimental	PRUNE2 VIM PDGFRA RCN1 CASP4 LCP1 GHR LTA4H DHTKD1 FMNL1	3.74e-03	774	139	10	C0023893
Disease	reticulocyte count	EPRS1 ARHGEF28 SPTA1 KBTBD8 PPIL6 LCP1 SKI F10 KLHL11 CCDC124 TBK1 L3MBTL3	3.97e-03	1045	139	12	EFO_0007986
Disease	haptoglobin measurement	DHX38 CMTR2	4.36e-03	21	139	2	EFO_0004640
Disease	venous thromboembolism, plasminogen activator inhibitor 1 measurement	F5 KIFAP3	4.36e-03	21	139	2	EFO_0004286, EFO_0004792

Protein segments in the cluster

Peptide	Gene	Start	Entry
ANEWKKKYEETRQEV	TACC1	621	O75410
GINWTDDEKRSYKDK	AGBL3	806	Q8NEM8
QDSKKQLEKAWKDYE	ASAP3	141	Q8TDY4
YQALVKAEQKKWEEQ	CEP152	876	O94986
KNDHQEDFWKVKEFL	RNPEP	581	Q9H4A4
KAQNEAKEIQDDWKY	CHRNA3	456	P32297
EQNVLNWKEEEKKKY	CASP4	31	P49662
VKNWVEFKKEFLQYS	ARC	261	Q7LC44
EKYEVTKKWSLNDLQ	EXOC1L	61	A0A1B0GW35
EKEKELCVKYFEQWS	BTRC	131	Q9Y297
YDNIKSFDIKAQWLK	CHIA	336	Q9BZP6
KDKVAKGYFNSWAEE	CMTR2	456	Q8IYT2
KWKDEDISQKDMYNI	HCCS	136	P53701
EYEKIKDSKFDDWKN	COX16	66	Q9P0S2
DEKDWFAKRFEELQK	DHTKD1	141	Q96HY7
DDWKKSESSREYKNN	CHD7	951	Q9P2D1
WYFDAEERAEAKKKF	EGLN3	211	Q9H6Z9
LAKWYMQFDDDEKQK	AP2S1	16	P53680
VAVEKFNAENYWKKK	AOX1	991	Q06278
KQSVEDILKDHWQKY	PGM1	406	P36871
SYQKKGFDIKWVDDT	R3HCC1L	666	Q7Z5L2
NFWNLLSEIEEKKYD	RAD51AP2	816	Q09MP3
IFDNVAKVWKDYDRD	RCN1	116	Q15293
VDWAVAKDKYKDTQS	RBM28	186	Q9NW13
KWKDTDNDELKVFFA	PGBD4	146	Q96DM1
KAVKDYEQEKSWQDS	INTS13	586	Q9NVM9
KILAEWKQKYEESQS	MYH7	1451	P12883
KEEEFNWQTYLKTCK	L3MBTL3	336	Q96JM7
SYFKDKVDVLNQVDW	LTA4H	431	P09960
VDLKVNEYEKNQKWL	ARHGEF28	1041	Q8N1W1
KVAFEFWQVSKEEKE	LDLRAP1	166	Q5SW96
QKDLKFLSEEEYWKL	CCNC	26	P24863
VTYKNEEDKLKDWEG	PDGFRA	991	P16234
FNWEDVKTDKQRENY	MMTAG2	16	Q9BU76
KIADEKYNDTFWKEF	HSP90B2P	131	Q58FF3
TEAQVFKAKFKNWDD	FLII	826	Q13045
FKAKFKNWDDVLTVD	FLII	831	Q13045
DKQAINEYEKWLENK	MAP9	596	Q49MG5
NEYEKWLENKEKQER	MAP9	601	Q49MG5
YAKKEEWKKAEEQLA	NCF2	131	P19878
EKNRKDAEEWFFTKT	KRT14	296	P02533
QYHKELQEWKDEKVR	CFAP65	1531	Q6ZU64
KYEENLKAELTNWIK	DDX60L	1051	Q5H9U9
EAVNDFYAAKKTWDI	CCDC178	416	Q5BJE1
IFKKLFDKWQTESND	FSIP2	2836	Q5CZC0
EYTIDVFFRQKWKDE	GABRA2	86	P47869
NFDKVLSEWKQKYEE	MYH8	1451	P13535
EEKYAFVNWINKALE	LCP1	121	P13796
KDFNLSKETVKWYQL	PIK3C2A	1666	O00443
AAKNLQEAEEWYKSK	PRPH	276	P41219
FWTKQKASKEQEGEY	PECAM1	556	P16284
YSDQNLQELEKWLKK	NNMT	86	P40261
KEKDLCIKYFDQWSE	FBXW11	71	Q9UKB1
NYDWKELEKNTEYKG	HERC4	946	Q5GLZ8
SEQKYNADRKKWLEE	KIF20B	1451	Q96Q89
TYVFKAKDEKNAEEW	VEPH1	796	Q14D04
TDLENKIKEWYDKYG	KRT24	166	Q2M2I5
KKGFYKQDVNKTAWE	MAPK13	6	O15264
DEWKQHIYKEIVNFS	MAPK13	336	O15264
QNDWLHEGFKKKYEE	GBP6	556	Q6ZN66
DDKNEEWYRLQEKKM	ANKRD49	56	Q8WVL7
YLQEKKRELKNETWE	PPIL6	71	Q8IXY8
AQLKNWKEYLEFEIE	PRPF39	351	Q86UA1
FEAWQEKQKELEDKE	LRRIQ1	171	Q96JM4
AYDIELNKWTRKKDF	KBTBD8	501	Q8NFY9
KLEQEAQKNWDLFYK	METTL6	36	Q8TCB7
EVQDLQASLKEEKWY	EEA1	91	Q15075
EKEEKEKLWYYSQLQ	APC2	146	O95996
EFNKYDTDGSKWIKQ	ACTR3	241	P61158
GWKNSDDIDKQYRKE	KLHL11	616	Q9NVR0
KNRKDAEDWFFSKTE	KRT17	266	Q04695
EYLQEKAKEKYQEWL	CCDC34	226	Q96HJ3
EYELQYKEVNETKWK	GHR	191	P10912
WKKILEDDKGAFQLY	FBXO5	281	Q9UKT4
DIEYKNKSDSWDFKQ	DSCAML1	921	Q8TD84
AKWQFYLEERKISKD	ADPRHL1	226	Q8NDY3
QWKVLNYDKTKDLED	MARCHF4	311	Q9P2E8
DKVQLLSQYDNEKKW	FMNL1	51	O95466
AYKKAEQEVEQWKKE	FMNL1	996	O95466
DEYQWLQIDLNKEKK	DCBLD2	346	Q96PD2
WQKENEEDLKDKLDF	DNAAF5	316	Q86Y56
KEHYEKISENWEEKK	FAM186A	851	A6NE01
FEDSDKTNEFWNKYK	F10	71	P00742
KYNNKTYRVDDIDWK	PIWIL3	326	Q7Z3Z3
NKGVKTEYKQFWDVD	SCAF8	551	Q9UPN6
EQDEFEKIYKNAWAD	SACM1L	426	Q9NTJ5
EEVVWSKFNSKEKQY	NLGN2	566	Q8NFZ4
ADAKKQKELEDAYWK	CCDC124	26	Q96CT7
KFLIYAQDKETQEKW	CDH2	101	P19022
AEYDEEWAKKIQSEK	KIFAP3	661	Q92845
ESEKKFLWKYVNRND	MRC1	841	P22897
YQWLKDKVQSEDGKK	KCNAB3	311	O43448
KRTWNYLEFEEEENK	GLMN	266	Q92990
LEAKKEENLADWYSQ	EPRS1	1016	P07814
KVYEKVDSWNLFEEN	PRUNE2	911	Q8WUY3
WLDKNKDYINFIQEK	SLC9C1	871	Q4G0N8
DIKNVLDFYKQWKEI	SMG5	1001	Q9UPR3
FDENKSWYLEDNINK	F5	551	P12259
FSQIYQWDKEKQLFK	LGI2	486	Q8N0V4
KQFFKDWRDKDQSDG	SCIN	341	Q9Y6U3
WKYFGKNDDDKLTEK	RCVRN	156	P35243
AKEKLDQLKQEFEFW	LARS1	651	Q9P2J5
FQQEYVKTEKDWREI	SAMD3	291	Q8N6K7
FDEKKQKWEEARAKY	TAF1B	411	Q53T94
KYLVTEWLNDKAEKQ	SETD5	701	Q9C0A6
EMEKVYSELKWQEKN	TEKT2	271	Q9UIF3
RNFDKVLAEWKQKYE	MYH4	1451	Q9Y623
VLAEWKQKYEETQAE	MYH4	1456	Q9Y623
DEKAGQKEQAVEWYK	SPAST	136	Q9UBP0
QKEQAVEWYKKGIEE	SPAST	141	Q9UBP0
YELAFKKQEEAWEQA	IL9R	181	Q01113
EWQVYKEEISRFKEQ	TFAM	106	Q00059
KENWKNLSDSEKELY	TFAM	186	Q00059
FDKILAEWKQKYEES	MYH6	1451	P13533
YFKGQWEKKFNKEDT	SERPINB3	181	P29508
KIQWYKDSLLLDKDN	IL1R2	166	P27930
RWAQEAYKKESAKEA	SKI	41	P12755
SYQKNDWRDAEENKK	CALD1	171	Q05682
FDYLWANKKTVDEKE	CNGA3	441	Q16281
KDNAKWYITDFVELL	PSPH	206	P78330
YLSQWQDELFKKEEN	TBC1D8B	966	Q0IIM8
YNSIKNEKLEWAIDE	PSD2	456	Q9BQI7
KWQLNLYKDVLKSEE	RYR3	3426	Q15413
FRYKENSKVDDKWEK	VPS35	541	Q96QK1
YWKEKRQNDKIDGEE	TRIM51	361	Q9BSJ1
KNLEKENYDVWAKVV	ARHGAP25	576	P42331
AKNLQEAEEWYKSKF	VIM	281	P08670
VSSYKDWEESKDDQK	DHX38	76	Q92620
KLYEDSDDLKNWINK	SPTA1	586	P02549
NWINKKKKLADDEDY	SPTA1	596	P02549
DDVWELQKKFDEFQK	SPTA1	1111	P02549
LKWYLNKIKFDQSVD	YME1L1	516	Q96TA2
FYELWLKSQKNEKSE	ZC3H7A	816	Q8IWR0
QKLLDLYESVDKQKW	TTC37	101	Q6PGP7
YWKEKNQNEKIDGED	TRIM49B	361	A6NDI0
FKVYWELTDLNQIKD	ITFG1	381	Q8TB96
DWIEKKLEQEFQKVF	TEX2	1076	Q8IWB9
TSIGKKWKDQNIEYE	ZNF763	41	Q0D2J5
EKKQTYKWSGFTEQD	ARHGAP21	521	Q5T5U3
DDSKDTWKKRGNVEY	USP8	241	P40818
KDFQVKKIYELAVWD	ZNF318	1946	Q5VUA4
VKKYEAFLNKSEEWI	TBK1	606	Q9UHD2
RWENKELSTKKDNYD	ZNF181	81	Q2M3W8
DEIFIDSAWKKNYIK	TMPRSS11A	86	Q6ZMR5
LNKEYTNWEAKETKA	TTF2	281	Q9UNY4
TSIGKKWKDQNIEYE	ZNF439	56	Q8NDP4
SLDYFEKQKAEWQTE	ZC4H2	131	Q9NQZ6
STEWQEKHKELQKEY	GOLGB1	1601	Q14789
VYNWDAEKAKFVKFQ	LGI1	501	O95970
SYEWGEDFKKVLQKN	NAALADL2	506	Q58DX5
RKRKAKNWEDEDFYD	SLC4A1AP	451	Q9BWU0
LSDNLYKQDWEKSKA	NEB	556	P20929
QSEREYKKDFEKWKT	NEB	2341	P20929
IQSDREYKKDFEKWK	NEB	2826	P20929
QSDREYKKEFEKWKT	NEB	3556	P20929
NDAQKFIYESDVLWK	NMNAT1	191	Q9HAN9